Okjae Lim

Phase I Study of Random Healthy Donor–Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors

Yaewon Yang, Okjae Lim, Tae Min Kim et al. · Cancer Immunology Research · 2016 · 153 citations

Life Sciences, Immunology, Oncology +17

GMP-Compliant, Large-Scale Expanded Allogeneic Natural Killer Cells Have Potent Cytolytic Activity against Cancer Cells In Vitro and In Vivo

Okjae Lim, Yuna Lee, Hyejin Chung et al. · PLoS ONE · 2013 · 78 citations · Full text

Life Sciences, Immunology, Oncology +11

Abrogation of HLA surface expression using CRISPR/Cas9 genome editing: a step toward universal T cell therapy

Jeewon Lee, Joong Hyuk Sheen, Okjae Lim et al. · Scientific Reports · 2020 · 54 citations · Full text

Life Sciences, Biotechnology, Immunology +17

Safety and immune cell kinetics after donor natural killer cell infusion following haploidentical stem cell transplantation in children with recurrent neuroblastoma

Young Bae Choi, Meong Hi Son, Hee Won Cho et al. · PLoS ONE · 2019 · 19 citations · Full text

Medicine, Immunology, Oncology +17

Adjuvant therapy using <i>ex vivo</i>-expanded allogenic natural killer cells in hepatectomy patients with hepatitis B virus related solitary hepatocellular carcinoma: MG4101 study

Jong Man Kim, Sung Yoo Cho, Jinsoo Rhu et al. · Annals of Hepato-Biliary-Pancreatic Surgery · 2021 · 12 citations · Full text

Medicine, Immunology, Oncology +11